Latest updates for Celg.rt

Fresh curated links around CELG.RT are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript
  • Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts
  • Major earnings expected before the bell on Tuesday include:

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

seekingalpha.com /2 days ago

Genomma Lab Internacional, S.A.B. de C.V. (GNMLF) Q3 2026 Earnings Call Transcript

Read source
seekingalpha.com /1 month ago

Tyra Biosciences: 'Hold' IR-NMIBC Data September 9th 2026, With Caution Ahead For 2027 Readouts

Read source
seekingalpha.com /3 weeks ago

Major earnings expected before the bell on Tuesday include:

Read source
seekingalpha.com /1 month ago

Olema: Best Breast Cancer Therapy, Or SERD Also-Ran? We'll Find Out In Q1 '27

Read source
seekingalpha.com /1 month ago

RTX Corporation: Backlog Boom Meets Cash Flow Inflection

Read source
seekingalpha.com /1 week ago

Celsius: How Alani Nu Will Lead This Name To A Turnaround

Read source
seekingalpha.com /2 days ago

Grupo Rotoplas S.A.B. de C.V. (GRPRF) Q3 2026 Earnings Call Transcript

Read source
fool.com /19 hours ago

Celsius vs. Colgate-Palmolive: Which Stock Should Investors Consider Before the Start of 2027?

One is a growth stock but faces Pepsi dependency; the other is a more mature company but has massive operating cash flow.

Read source
seekingalpha.com /1 month ago

GENDA Inc. 2027 Q2 - Results - Earnings Call Presentation

Read source
seekingalpha.com /3 weeks ago

CeriBell: FDA Clearances And Delirium Expansion Could Create A New Growth Driver

Read source
seekingalpha.com /1 day ago

RingCentral surges after 'dialing up' revenue acceleration: analysts

Read source
seekingalpha.com /1 month ago

AT&T Preferred Cumulative Shares Series A And C Seeking A Bid

Read source
pharmexec.com /1 month ago

<![CDATA[M&A Roundup: DualityBio & Genentech Enter Partnership to Develop Next Generation ADC’s, Teva Bids to...

Read source
seekingalpha.com /1 month ago

Cardiol Therapeutics: Q1 2027 Readout Will Be Make-Or-Break For Maveric

Read source
seekingalpha.com /1 month ago

Ferroglobe PLC: Navigating Metal Uncertainty

Read source
pharmexec.com /1 day ago

<![CDATA[Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targ...

Read source
seekingalpha.com /2 weeks ago

Opus Genetics, Inc. (IRD) Presents at Euretina 2026 - Slideshow

Read source
seekingalpha.com /2 days ago

Rogers Q3 2026 Earnings Preview

Read source
seekingalpha.com /1 month ago

Cellebrite DI Ltd. (CLBT) Discusses Leadership Transition and Strategic Focus on Growth and Execution Transcript

Read source
seekingalpha.com /1 week ago

Collegium Pharmaceutical: Under 3x Cash Earnings After A Narrow Guidance Cut

Read source
seekingalpha.com /1 month ago

BioArctic AB (publ) (BRCTF) Q2 2026 Earnings Call Transcript

Read source
seekingalpha.com /2 weeks ago

RIV's Rights Offering Results

Read source
seekingalpha.com /3 weeks ago

Astera Labs: Promising Growth, Concentrated Revenue, And A Demanding Price

Read source
seekingalpha.com /1 month ago

Smaregi, Inc. 2027 Q1 - Results - Earnings Call Presentation

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Celg.rt

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

fool.com

Recent coverage from public sources
Public source

pharmexec.com

Recent coverage from public sources
Public source